Welcome to LookChem.com Sign In|Join Free

CAS

  • or

63293-52-7

Post Buying Request

63293-52-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

63293-52-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 63293-52-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,2,9 and 3 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 63293-52:
(7*6)+(6*3)+(5*2)+(4*9)+(3*3)+(2*5)+(1*2)=127
127 % 10 = 7
So 63293-52-7 is a valid CAS Registry Number.

63293-52-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxyethyl 2-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxybenzoate

1.2 Other means of identification

Product number -
Other names Benzoic acid,2-(2-(4-chlorophenoxy)-2-methyl-1-oxopropoxy)-,2-(2-(4-chlorophenoxy)-2-methyl-1-oxopropoxy)ethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:63293-52-7 SDS

63293-52-7Downstream Products

63293-52-7Relevant articles and documents

Hypolipemic activity of clofibrate related compounds. II

Metz,Specker

, p. 1421 - 1424 (2007/10/07)

Clofibrate-related compounds were synthesized from substituted phenoxyacetic acids by esterification with salicylic acid derivatives, by amidation of thiazolidines or by reaction with cinnarizine. Lipid lowering effect was investigated in normolipemic and hyperlipemic rats. The long-term hyperlipemic model used permits differentiation of hypolipemic efficacy, i.e. from clofibrate or compounds of similar activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 63293-52-7